Cornileus Pharmaceuticals Private Limited - Due diligence report

A 360° intelligence report on Cornileus Pharmaceuticals Private Limited: trust score, financial health, credit view, compliance, directors, …

2001-12-28 Hyderabad, Telangana Active Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Cornileus Pharmaceuticals Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
76/100
Trust Score
Low Risk

Cornileus Pharmaceuticals Private Limited is assessed as Low Risk with a Trust Score of 76/100. Cornileus Pharmaceuticals Private Limited is an active private limited indian non-government company incorporated in 2001, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 30 Oct 2026 from the latest processed filings. Cornileus Pharmaceuticals Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
76/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
38/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 2 open (17.00 cr) · 7 satisfied (66.56 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others3 48.0 cr
State Bank Of India1 48.0 cr
3I Infotech Trusteeship Services Limited1 48.0 cr
Andhra Bank3 48.0 cr
Export-Import Bank Of India1 48.0 cr
Compliance Score: 38/100 Caution Indicated
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2024 - filings overdue.
  • Flagged by authority: NCLT.
  • Litigation present in 1 court forum(s).
  • 2 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
JAGARLAMUDI SURESH BABU 01234567 Director 01/04/2018 6 yrs Approved
KIRAN KUMAR NALAMOTHU 01234567 Director 01/04/2018 6 yrs Approved
VENKAT SAMRAJ JAGARLAMUDI 01234567 Director 01/04/2018 6 yrs Approved
VIJAYALAKSHMI NALAMOTHU 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2022)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold the largest single block of equity - exact percentages are part of the full report.

Key managerial personnel: KIRAN KUMAR NALAMOTHU (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 75 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 24+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Statutory filings appear overdue.
Compliance score is weak (38/100).
2 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence62/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment81/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 17.00 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view82/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
20 Jun 2025
Charge satisfied
State Bank Of India
25 Sep 2024
Last AGM held
Annual general meeting
06 May 2024
Charge created
Others - 7.50 cr
31 Mar 2024
Latest balance sheet
Filed with ROC
25 Oct 2021
Director ceased
JAGARLAMUDI SURESH BABU
Director ceased
VENKAT SAMRAJ JAGARLAMUDI
28 Dec 2020
Director appointed
JAGARLAMUDI SURESH BABU (Director)
Director appointed
VENKAT SAMRAJ JAGARLAMUDI (Director)
Director ceased
SAMPATH KUMAR KANDUKURI
07 Feb 2020
Charge created
State Bank Of India - 31.71 cr
01 Feb 2019
Charge created
Others - 9.50 cr
22 Nov 2018
Charge satisfied
Others
05 Nov 2018
Director appointed
KIRAN KUMAR NALAMOTHU (Managing Director)
08 Sep 2018
Director ceased
VIJAYALAKSHMI NALAMOTHU
17 Oct 2017
Director appointed
VIJAYALAKSHMI NALAMOTHU (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
4 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold the largest single block of equity as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Jajoo Surgical U01810MP1991PTC006264 Indore, Madhya Pradesh, India
Suchir Chemicals Private Limited U24110MH1998PTC114423 Mumbai, Maharashtra, India
Stermone Chemicals Private Limited U24110GJ2005PTC047409 Khambhat, Gujarat, India
Biomylz Private Limited U33208KA2017PTC100964 Bangalore, Karnataka, India
Shree Anand Life Sciences U24232KA2006PLC040855 Belgaum, Karnataka, India
Ruia Chemicals Pvt Ltd U24222WB1976PTC030788 Kolkata, West Bengal, India
Growtech Agri Science And Research Private Limited U24200MP2010PTC024231 Indore, Madhya Pradesh, India
K. B. Aromatics Private Limited U51102UP1998PTC024036 Lucknow, Uttar Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Cornileus Pharmaceuticals Private Limited before audits and certifications: compliance score 38/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Cornileus Pharmaceuticals Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 75/100, margin trends, ownership structure and peer set for Cornileus Pharmaceuticals Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 76/100, distress signals and MSME payment-delay disclosures - know whether Cornileus Pharmaceuticals Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Cornileus Pharmaceuticals Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Cornileus Pharmaceuticals Private Limited an active company?

Cornileus Pharmaceuticals Private Limited has MCA status “Active” with a compliance score of 38/100 (Caution Indicated).

Is Cornileus Pharmaceuticals Private Limited financially healthy?

Cornileus Pharmaceuticals Private Limited has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Cornileus Pharmaceuticals Private Limited?

Its overall Trust Score is 76/100 (Low Risk). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Cornileus Pharmaceuticals Private Limited?

Promoters hold the largest single block of equity - exact percentages are in the full report. 4 active director(s) are on record.

Does Cornileus Pharmaceuticals Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets, and 7 earlier charge(s) stand satisfied.

Is Cornileus Pharmaceuticals Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2024 - filings overdue. Overall compliance score: 38/100 (Caution Indicated).

Is it risky to lend to Cornileus Pharmaceuticals Private Limited?

Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.